A phase I pharmacokinetic study to compare the steady-state pharmacokinetics of testosterone following application of a Testosterone Metered-Dose Transdermal Spray (MDTS) to the forearm or abdomen in healthy postmenopausal women with low libido and low serum testosterone

Phase 1

Completed

• Conditions: ow libido in post-menopausal women with low serum testosterone; Low libido in post-menopausal women with low serum testosterone; Reproductive Health and Childbirth - Menstruation and menopause

• Registration Number: ACTRN12605000522617
• Lead Sponsor: FemPharm Pty Ltd and/or Acrux DDS Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 14

Inclusion Criteria

Healthy post-menopausal women

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified